학술논문
Subcutaneous Immunoglobulin 16.5% (Cutaquig) in Primary Immunodeficiency Disease: Safety, Efficacy, and Patient Satisfaction with Modified Dosing Regimens
Document Type
Abstract
Author
Source
In Clinical Immunology May 2023 250 Supplement
Subject
Language
ISSN
1521-6616